ArticleAmyotrophic lateral sclerosis & frontotemporal degeneration2020
Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis.
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 31 citations in OpenAlex.
- Review
- Metabolomic analyses of amyotrophic lateral sclerosis, muscle cramps, and TJ-68 treatment.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Oxidative-Nitrosative Stress and Routine Biochemical Parameters in Amyotrophic Lateral Sclerosis: Associations with Clinical Status and Disease Duration-A Pilot Study.Biomolecules · 2026Article
- Caffeine mitigates ROS accumulation and attenuates motor neuron degeneration in the wobbler mouse model of amyotrophic lateral sclerosis.Cell communication and signaling : CCS · 2025Article
- Serum creatinine as a risk factor for endometriosis: insights from cross-sectional study, mendelian randomization analysis, and diagnostic model study.BMC women's health · 2025Article
- Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications.Acta pharmaceutica Sinica. B · 2025Review
- Urinary P75: a promising biomarker for amyotrophic lateral sclerosis.BMJ neurology open · 2025Article
- The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era.Biomedicines · 2024Review
- Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis.Annals of neurology · 2024Article
- Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders.Current topics in medicinal chemistry · 2024Review
- Differential Expression of miRNAs in Amyotrophic Lateral Sclerosis Patients.Molecular neurobiology · 2023Article
- Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis.Brain sciences · 2023Article
- Venous blood parameters in determination of respiratory impairment in amyotrophic lateral sclerosis.Scientific reports · 2023Article
- Defects in Glutathione System in an Animal Model of Amyotrophic Lateral Sclerosis.Antioxidants (Basel, Switzerland) · 2023Article
- Review
- Review
- Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations.Brain communications · 2023Review
- Plasma taurine is an axonal excitability-translatable biomarker for amyotrophic lateral sclerosis.Scientific reports · 2022Article
- Association of Oxidative Stress with Neurological Disorders.Current neuropharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 14 institutions in 1 country.
Hiroshi MitsumotoDepartment of Neurology, Eleanor and Lou Gehrig ALS Center, Columbia University Irving Medical Center, New York, NY, USA.
Diana C GarofaloDepartment of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA.
Regina M SantellaDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA.
Eric J SorensonDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Björn OskarssonDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0002-1725-9866
J Americo M FernandesDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Howard AndrewsData Coordinating Center (DCC), Mailman School of Public Health Biostatistics Department, Columbia University Irving Medical Center, New York State Psychiatric Institute & Department of Psychiatry, Columbia University.
Jonathan HupfDepartment of Neurology, Eleanor and Lou Gehrig ALS Center, Columbia University Irving Medical Center, New York, NY, USA.
Madison GilmoreDepartment of Neurology, Eleanor and Lou Gehrig ALS Center, Columbia University Irving Medical Center, New York, NY, USA.
Daragh HeitzmanTexas Neurology, PA, Dallas, TX, USA.
Richard S BedlackDepartment of Neurology, Duke University, Durham, NC, USA.
Jonathan S KatzForbes Norris ALS Center, California Pacific Medical Center, San Francisco, CA, USA.
Richard J BarohnDepartment of Neurology, University of Kansas, San Francisco, CA, USA.
Edward J KasarskisDepartment of Neurology, University of Kentucky, San Francisco, CA, USA.
Catherine Lomen-HoerthDepartment of Neurology, University of California, San Francisco, CA, USA.
Tahseen MozaffarDepartment of Neurology, University of California, Irvine, CA, USA.
Sharon P NationsDepartment of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA, and.
Andrea J SwensonDepartment of Neurology, University of Iowa, Iowa City, IA, USA.
Pam Factor-LitvakDepartment of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA.
Columbia University Irving Medical Center · USCalifornia Pacific Medical Center · USDuke University · USMayo Clinic in Arizona · USNew York Psychoanalytic Society and Institute · USTexas Neurology · USThe University of Texas Southwestern Medical Center · USUniversity of California, Irvine · USUniversity of California, San Francisco · USUniversity of Iowa · USUniversity of Kansas · USUniversity of Kentucky · USUniversity of Nebraska Medical Center · USWinnMed · US
Funding
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7MMulticenter ALS Cohort Study of Oxidative Stress and Disease ProgressionR01ES016348 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MITSUMOTO, HIROSHI · 2009 to 2013
$3.5MNIEHS NIH HHS P30 ES009089NIEHS NIH HHS R01 ES016348
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedAged, 80 and overAmyotrophic Lateral SclerosisBiomarkersCohort StudiesCreatinineCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedOxidative StressProspective StudiesSurvival RateBiomarkersCreatinineUric AcidAmyotrophic lateral sclerosisbiomarkercreatinineoxidative stressuric acid
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.